| 摘要 |
Use of compounds of the formula (I) in which R<1>, R<4>, R<2>, R<4 >and R<5 >are as defined in claim 1, and physiologically acceptable salts and solvates thereof, for the treatment of obesity, sub-types of anxiety, sub-types of schizophrenia and types of dementia of various origin. |
